Cited by 341Autism Spectrum Disorder ResearchGenetics and Neurodevelopmental DisordersPharmacological Effects and Toxicity Studies

Autism-like behaviours with transient histone hyperacetylation in mice treated prenatally with valproic acid

Open access
Kataoka, Shunsuke, Takuma, Kazuhiro, Hara, Yuta, Maeda, Yuko, Ago, Yukio, Matsuda, Toshio·2013·International Journal of Neuropsychopharmacology

Abstract

Maternal use of valproic acid (VPA) during pregnancy has been implicated in the aetiology of autism spectrum disorders in children, and rodents prenatally exposed to VPA showed behavioural alterations similar to those observed in humans with autism. However, the exact mechanism for VPA-induced behavioural alterations is not known. To study this point, we examined the effects of prenatal exposure to VPA and valpromide, a VPA analog lacking histone deacetylase inhibition activity, on behaviours, cortical pathology and histone acetylation levels in mice. Mice exposed to VPA at embryonic day 12.5 (E12.5), but not at E9 and E14.5, displayed social interaction deficits, anxiety-like behaviour and memory deficits at age 4–8 wk. In contrast to male mice, the social interaction deficits (a decrease in sniffing behaviour) were not observed in female mice at age 8 wk. The exposure to VPA at E12.5 decreased the number of Nissl-positive cells in the middle and lower layers of the prefrontal cortex and in the lower layers of the somatosensory cortex at age 8 wk. Furthermore, VPA exposure caused a transient increase in acetylated histone levels in the embryonic brain, followed by an increase in apoptotic cell death in the neocortex and a decrease in cell proliferation in the ganglionic eminence. In contrast, prenatal exposure to valpromide at E12.5 did not affect the behavioural, biochemical and histological parameters. Furthermore, these findings suggest that VPA-induced histone hyperacetylation plays a key role in cortical pathology and abnormal autism-like behaviours in mice.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1017/s1461145711001714

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Cell density is increased in the neocortex with low-dose VPA and decreased in the prefrontal and somatosensory cortex with high-dose VPA.

    “Cell density is increased in the neocortex with a low dose [307] and decreased in the prefrontal and somatosensory cortex with a high dose of VPA [186].”

    From Autism spectrum disorder: neuropathology and animal models (2017) · cites this paper as [186]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Kataoka, S., Takuma, K., Hara, Y., Maeda, Y., Ago, Y., & Matsuda, T.
Affiliations
  • The University of Osaka (JP)
  • Kanazawa University (JP)
Corresponding author
Matsuda, Toshio
Venue
International Journal of Neuropsychopharmacology
Published
2013-02-01
Volume
16
Issue
1
Pages
91-103
ISSN
  • 1461-1457 (ISSN-L)
  • 1469-5111
OpenAlex
W2163492066
Cited by
341
References
56
Citations by year
2026: 15 · 2025: 33 · 2024: 30 · 2023: 30 · 2022: 40 · 2021: 26 · 2020: 24 · 2019: 26 · 2018: 15 · 2017: 24 · 2016: 27 · 2015: 16 · 2014: 11 · 2013: 18 · 2012: 6
FWCI
5.67
Type
journal article
Language
en
Open access
Locations
  • The International Journal of Neuropsychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
Funders
Japan Society for the Promotion of Science
Topics
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmacological Effects and Toxicity Studies
Keywords
valproic acid, prenatal drug exposure, autism spectrum disorder, histone hyperacetylation, histone deacetylase inhibition, valpromide, social interaction deficits, anxiety-like behavior, memory impairment, cortical pathology, prefrontal cortex, somatosensory cortex, neuronal apoptosis, ganglionic eminence, sex differences
MeSH terms
Acetylation, Animals, Autistic Disorder, Cell Movement, Cerebral Cortex, Female, Histones, Interpersonal Relations, Male, Mice, Inbred ICR, Pregnancy, Prenatal Exposure Delayed Effects, Valproic Acid, Maze Learning, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review